Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Reviva Pharmaceuticals Holdings, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 31 | 2 | 33 | +4 |
| Shares | 6.85M | 115.3K | 9.95M | +3.21M (+47.7%) |
| Value | $8.75M | $147.6K | $14.3M | +$5.70M (+66.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 3,186,000 | $4.59M | 0.12% |
| BlackRock, Inc. | 104,690 | $150.8K | 0.00% |
| Avantax Advisory Services, Inc. | 60,000 | $86.4K | 0.00% |
| Virtu Financial LLC | 14,266 | $21.0K | 0.00% |
| Two Sigma Securities, LLC | 13,944 | $20.1K | 0.00% |
| Citadel Advisors LLC | 13,508 | $19.5K | 0.00% |
| Commonwealth Equity Services, LLC | 12,342 | $18.0K | 0.00% |
| Deutsche Bank AG | 2,000 | $2.88K | 0.00% |
| Godsey & Gibb Associates | 1,600 | $2.30K | 0.00% |
Sold out (5)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Sabby Management, LLC | 236,997 | $303.4K |
| Simplex Trading, LLC | 2,420 | $3.00K |
| Archer Investment Corp | 500 | $640 |
| Qube Research & Technologies Ltd | 50 | $64 |
| Royal Bank of Canada | 235 | $0 |
Not filed for Q3 2024 yet (2)
Institutions that held Reviva Pharmaceuticals Holdings, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 102,932 | $131.8K |
| NRI Wealth Management LC | 12,380 | $15.8K |